{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:35:56Z","timestamp":1782930956109,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Methylmalonic acidemia (MMA) secondary to mutase deficiency,\n                      <jats:italic>mut0<\/jats:italic>\n                      , is an inborn error of metabolism causing complete enzyme defect, allowing a high risk of irreversible complications, secondary to metabolic decompensation, induced by infections and the hyperinflammatory state.\n                    <\/jats:p>\n                    <jats:p>Multisystem Inflammatory Syndrome in Children (MIS-C) is a hyperinflammatory syndrome that manifests 14\u201360\u00a0days after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients aged\u2009&lt;\u200921\u00a0years. Only a few cases of patients with inherited metabolic diseases (IMD) and MIS-C are described. However, to our knowledge, this is the first case of MMA with MIS-C.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      We describe a 2-year-old child with MMA secondary to mutase deficiency, carrying the homozygous mutation c.2179 C\u2009&gt;\u2009T of\n                      <jats:italic>MMUT<\/jats:italic>\n                      gene, associated to\n                      <jats:italic>mut0<\/jats:italic>\n                      phenotype.\n                    <\/jats:p>\n                    <jats:p>One month after SARS-CoV-2 infection, he presented fever, rash, significant increase of C-reactive protein (CRP), ferritin, triglycerides, interleukin (IL)-6, N-terminal fragment of the pro brain natriuretic peptide (NT-pro-BNP), compatible with the diagnosis of MIS-C. He was treated with intravenous immunoglobulins and methylprednisolone, with rapid clinical improvement. Ten days later, he showed the worsening of clinical and hematological parameters, associated with anemia, thrombocytopenia, metabolic acidosis, hyperlactatemia, increased urinary methylmalonic acid, leading to multiorgan failure (MOF). He was treated with high caloric intake nutrition by intravenous carbohydrates infusion; sodium bicarbonate, thiamine, carnitine, coenzyme Q, vitamin C, antibiotics, methylprednisolone and anakinra. Three days after the start of anakinra, a significant improvement in clinical and biochemical parameters occurred. Twenty days later, a sepsis from Methicillin-resistant Staphylococcus Aureus and Candida Albicans required the interruption of anakinra, with the decline of the clinical conditions and the exitus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with a severe form of MMA and MIS-C anakinra is a safe treatment. MOF and metabolic decompensation, secondary to the hyperinflammatory state typical of MIS-C, can be successfully treated with targeted therapy against proinflammatory cytokines. The description of these clinical cases is a precious lesson in managing IMD therapeutic emergencies. Paediatricians must provide a strict monitoring of metabolic compensation, to avoid irreversible complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13052-025-02052-1","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T06:12:39Z","timestamp":1751350359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MIS-C, inherited metabolic diseases and methylmalonic acidemia: a case report and review of the literature"],"prefix":"10.1186","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7777-1239","authenticated-orcid":false,"given":"Maria Cristina","family":"Maggio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Castana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Caserta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Di Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Corsello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"2052_CR1","doi-asserted-by":"publisher","unstructured":"Melgar M, Lee EH, Miller AD, Lim S, Brown CM, Yousaf AR, Zambrano LD, Belay ED, Godfred-Cato S, Abrams JY, Oster ME, Campbell AP. Council of State and Territorial Epidemiologists\/CDC Surveillance Case Definition for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection - United States. MMWR Recomm Rep. 2022;71(4):1\u201314. https:\/\/doi.org\/10.15585\/mmwr.rr7104a1. PMID: 36520808; PMCID: PMC9762894.","DOI":"10.15585\/mmwr.rr7104a1"},{"issue":"4","key":"2052_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1002\/art.42062","volume":"74","author":"LA Henderson","year":"2022","unstructured":"Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, Behrens EM, Kernan KF, Schulert GS, Seo P, Son MBF, Tremoulet AH, VanderPluym C, Yeung RSM, Mudano AS, Turner AS, Karp DR, Mehta JJ. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3. Arthritis Rheumatol. 2022;74(4):e1\u201320. https:\/\/doi.org\/10.1002\/art.42062. (Epub 2022 Feb 3. PMID: 35118829; PMCID: PMC9011620).","journal-title":"Arthritis Rheumatol."},{"issue":"16","key":"2052_CR3","first-page":"36520808","volume":"71","author":"M Melgar","year":"2022","unstructured":"Melgar M, Lee EH, Miller AD, Lim S, Brown CM, Yousaf AR, Zambrano LD, Belay ED, Godfred F, Abrams JY, Oster ME, Campbell AP. Council of state and territorial epidemiologists. Epidemiologists\/CDC Surveillance Case Definition for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection United States. MMWR Recomm Rep. 2022;71(16):36520808 PMCID: PMC9762894.","journal-title":"MMWR Recomm Rep."},{"issue":"1","key":"2052_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13052-021-00962-4","volume":"47","author":"A Marchesi","year":"2021","unstructured":"Marchesi A, Rigante D, Cimaz R, Ravelli A, de Tarissi Jacobis I, Rimini A, Cardinale F, Cattalini M, De Zorzi A, Dellepiane RM, Salice P, Secinaro A, Taddio A, Palma P, El Hachem M, Cortis E, Maggio MC, Corsello G, Villani A. Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease. Ital J Pediatr. 2021;47(1):16. https:\/\/doi.org\/10.1186\/s13052-021-00962-4.","journal-title":"Ital J Pediatr."},{"issue":"1","key":"2052_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13052-016-0306-z","volume":"42","author":"MC Maggio","year":"2016","unstructured":"Maggio MC, Corsello G, Prinzi E, Cimaz R. Kawasaki disease in Sicily: clinical description and markers of disease severity. Ital J Pediatr. 2016;42(1):92. https:\/\/doi.org\/10.1186\/s13052-016-0306-z. (PMID:27806720;PMCID:PMC5094032).","journal-title":"Ital J Pediatr"},{"issue":"1","key":"2052_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13052-018-0536-3","volume":"44","author":"A Marchesi","year":"2018","unstructured":"Marchesi A, de Tarissi Jacobis I, Rigante D, Rimini A, Malorni W, Corsello G, Bossi G, Buonuomo S, Cardinale F, Cortis E, De Benedetti F, De Zorzi A, Duse M, Del Principe D, Dellepiane RM, D\u2019Isanto L, El Hachem M, Esposito S, Falcini F, Giordano U, Maggio MC, Mannarino S, Marseglia G, Martino S, Marucci G, Massaro R, Pescosolido C, Pietraforte D, Pietrogrande MC, Salice P, Secinaro A, Straface E, Villani A. Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase. Ital J Pediatr. 2018;44(1):102. https:\/\/doi.org\/10.1186\/s13052-018-0536-3. PMID: 30157897; PMCID: PMC6116535.","journal-title":"Ital J Pediatr."},{"issue":"1","key":"2052_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13052-018-0529-2","volume":"44","author":"A Marchesi","year":"2018","unstructured":"Marchesi A, de Tarissi Jacobis I, Rigante D, Rimini A, Malorni W, Corsello G, Bossi G, Buonuomo S, Cardinale F, Cortis E, De Benedetti F, De Zorzi A, Duse M, Del Principe D, Dellepiane RM, D\u2019Isanto LJ, El Hachem M, Esposito S, Falcini F, Giordano U, Maggio MC, Mannarino S, Marseglia G, Martino S, Marucci G, Massaro R, Pescosolido C, Pietraforte D, Pietrogrande MC, Salice P, Secinaro A, Straface E, Villani A. Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks. Ital J Pediatr. 2018;44(1):103. https:\/\/doi.org\/10.1186\/s13052-018-0529-2. PMID: 30157893; PMCID: PMC6116479.","journal-title":"Ital J Pediatr."},{"issue":"2","key":"2052_CR8","doi-asserted-by":"publisher","first-page":"107607","DOI":"10.1016\/j.ymgme.2023.107607","volume":"139","author":"AB Kahraman","year":"2023","unstructured":"Kahraman AB, Y\u0131ld\u0131z Y, \u00c7\u0131k\u0131 K, Erdal I, Akar HT, Dursun A, Tokatl\u0131 A, Sivri S. COVID-19 in inherited metabolic disorders: Clinical features and risk factors for disease severity. Mol Genet Metab. 2023;139(2):107607. https:\/\/doi.org\/10.1016\/j.ymgme.2023.107607. Epub 2023 May 11. PMID: 37201420; PMCID: PMC10171899.","journal-title":"Mol Genet Metab."},{"key":"2052_CR9","unstructured":"Manoli I, Sloan JL, Venditti CP. Isolated Methylmalonic Acidemia. 2005 Aug 16 [updated 2022 Sep 8]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae. Seattle (WA): University of Washington, Seattle; 1993\u20132025. PMID: 20301409."},{"issue":"11","key":"2052_CR10","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1097\/INF.0000000000003689","volume":"41","author":"LD Zambrano","year":"2022","unstructured":"Zambrano LD, Ly KN, Link-Gelles R, Newhams MM, Akande M, Wu MJ, Feldstein LR, Tarquinio KM, Sahni LC, Riggs BJ, Singh AR, Fitzgerald JC, Schuster JE, Giuliano JS Jr, Englund JA, Hume JR, Hall MW, Osborne CM, Doymaz S, Rowan CM, Babbitt CJ, Clouser KN, Horwitz SM, Chou J, Patel MM, Hobbs C, Randolph AG, Campbell AP, Overcoming COVID-19 Investigators. Investigating Health Disparities Associated With Multisystem Inflammatory Syndrome in Children After SARS-CoV-2 Infection. Pediatr Infect Dis J. 2022;41(11):891\u20138. https:\/\/doi.org\/10.1097\/INF.0000000000003689. Epub 2022 Sep 7. PMID: 36102740; PMCID: PMC9555608.","journal-title":"Pediatr Infect Dis J."},{"issue":"1","key":"2052_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/jimd.12348","volume":"44","author":"CR Ferreira","year":"2021","unstructured":"Ferreira CR, Rahman S, Keller M, Zschocke J, ICIMD Advisory Group. An international classification of inherited metabolic disorders (ICIMD). J Inherit Metab Dis. 2021;44(1):164\u201377. https:\/\/doi.org\/10.1002\/jimd.12348. PMID: 33340416; PMCID: PMC9021760.","journal-title":"J Inherit Metab Dis."},{"issue":"1","key":"2052_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s13023-020-01619-x","volume":"15","author":"C Lampe","year":"2020","unstructured":"Lampe C, Dionisi-Vici C, Bellettato CM, Paneghetti L, van Lingen C, Bond S, Brown C, Finglas A, Francisco R, Sestini S, Heard JM, Scarpa M, MetabERN collaboration group. The impact of COVID-19 on rare metabolic patients and healthcare providers: results from two MetabERN surveys. Orphanet J Rare Dis. 2020;15(1):341. https:\/\/doi.org\/10.1186\/s13023-020-01619-x. PMID: 33272301; PMCID: PMC7711270.","journal-title":"Orphanet J Rare Dis."},{"issue":"21","key":"2052_CR13","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.3390\/jcm10214862","volume":"10","author":"E Tob\u00f3r-\u015awi\u0119tek","year":"2021","unstructured":"Tob\u00f3r-\u015awi\u0119tek E, Sykut-Cegielska J, Bik-Multanowski M, Walczak M, Rokicki D, Ka\u0142u\u017cny \u0141, Wierzba J, Pac M, Jahnz-R\u00f3\u017cyk K, Wi\u0119sik-Szewczyk E, Kie\u0107-Wilk B. COVID-19 Pandemic and Patients with Rare Inherited Metabolic Disorders and Rare Autoinflammatory Diseases-Organizational Challenges from the Point of View of Healthcare Providers. J Clin Med. 2021;10(21):4862. https:\/\/doi.org\/10.3390\/jcm10214862. (PMID:34768381;PMCID:PMC8584872).","journal-title":"J Clin Med"},{"issue":"22","key":"2052_CR14","doi-asserted-by":"publisher","first-page":"e931570","DOI":"10.12659\/AJCR.931570","volume":"12","author":"S Giordano","year":"2021","unstructured":"Giordano S, Failla MC, Li Cavoli MG, Romano D, Vanella V, Caruso C, Chillura I, Maggio MC. A 7-Year-Old Boy and a 14-Year-Old Girl Initially Diagnosed with Toxic Shock Syndrome and Tested Positive for SARS-CoV-2 Infection, Supporting a Diagnosis of Multisystem Inflammatory Syndrome in Children (MIS-C). Am J Case Rep. 2021;12(22):e931570. https:\/\/doi.org\/10.12659\/AJCR.931570. (PMID:34635631;PMCID:PMC8522524).","journal-title":"Am J Case Rep"},{"issue":"1","key":"2052_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13052-023-01416-9","volume":"49","author":"MC Maggio","year":"2023","unstructured":"Maggio MC, Giordano S, Failla MC, Campione MG, Alaimo A, Corsello G. Ten-month follow-up of patients with covid-19 temporally related multi-system inflammatory syndrome in children: the experience of the children hospital of Palermo. Ital J Pediatr. 2023;49(1):37. https:\/\/doi.org\/10.1186\/s13052-023-01416-9. (PMID:36959663;PMCID:PMC10034232).","journal-title":"Ital J Pediatr"},{"issue":"1","key":"2052_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12969-021-00511-7","volume":"19","author":"M Cattalini","year":"2021","unstructured":"Cattalini M, Della Paolera S, Zunica F, Bracaglia C, Giangreco M, Verdoni L, Meini A, Sottile R, Caorsi R, Zuccotti G, Fabi M, Montin D, Meneghel A, Consolaro A, Dellepiane RM, Maggio MC, La Torre F, Marchesi A, Simonini G, Villani A, Cimaz R, Ravelli A, Taddio A, Rheumatology Study Group of the Italian Pediatric Society. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey. Pediatr Rheumatol Online J. 2021;19(1):29. https:\/\/doi.org\/10.1186\/s12969-021-00511-7. PMID: 33726806; PMCID: PMC7962084.","journal-title":"Pediatr Rheumatol Online J."},{"issue":"4","key":"2052_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/art.42411","volume":"75","author":"ED Batu","year":"2023","unstructured":"Batu ED, Sener S, Ozomay Baykal G, Arslanoglu Aydin E, \u00d6zdel S, Gagro A, Esen E, Heshin-Bekenstein M, Akp\u0131nar Tekg\u00f6z N, Demirkan FG, Ozturk K, Vougiouka O, Sonmez HE, Maggio MC, Kaya Akca U, Jelusic M, Pac K\u0131saarslan A, Acar B, Aktay Ayaz N, S\u00f6zeri B, \u00d6zen S, Pediatric Rheumatology European Society (PReS) Vasculitis Working Party. The Characteristics of Patients With COVID-19-Associated Pediatric Vasculitis: An International. Multicenter Study. Arthritis Rheumatol. 2023;75(4):499\u2013506. https:\/\/doi.org\/10.1002\/art.42411. Epub 2023 Jan 23. PMID: 36457245; PMCID: PMC9877558.","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"2052_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1055\/a-1952-1946","volume":"123","author":"JL Gu\u00e9ant","year":"2023","unstructured":"Gu\u00e9ant JL, Gu\u00e9ant-Rodriguez RM, Oussalah A, Zuily S, Rosenberg I. Hyperhomocysteinemia in Cardiovascular Diseases: Revisiting Observational Studies and Clinical Trials. Thromb Haemost. 2023;123(3):270\u201382. https:\/\/doi.org\/10.1055\/a-1952-1946. Epub 2022 Sep 28 PMID: 36170884.","journal-title":"Thromb Haemost"},{"issue":"1","key":"2052_CR19","doi-asserted-by":"publisher","first-page":"e14938","DOI":"10.1111\/ped.14938","volume":"64","author":"T Zubarioglu","year":"2022","unstructured":"Zubarioglu T, Hopurcuoglu D, Ahmadzada S, Uzunyayla-Inci G, Cansever MS, Kiykim E, Aktuglu-Zeybek C. Inborn errors of metabolism and coronavirus disease 2019: Evaluation of the metabolic outcome. Pediatr Int. 2022;64(1):e14938. https:\/\/doi.org\/10.1111\/ped.14938. PMID:34329521;PMCID:PMC8447071.","journal-title":"Pediatr Int"},{"issue":"1","key":"2052_CR20","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s13023-020-01563-w","volume":"15","author":"A Caciotti","year":"2020","unstructured":"Caciotti A, Procopio E, Pochiero F, Falliano S, Indolfi G, Donati MA, Ferri L, Guerrini R, Morrone A. SARS-CoV-2 infection in a patient with propionic acidemia. Orphanet J Rare Dis. 2020;15(1):306. https:\/\/doi.org\/10.1186\/s13023-020-01563-w. PMID:33115512;PMCID:PMC7592193.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2052_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/jimd.12572","volume":"46","author":"U M\u00fctze","year":"2023","unstructured":"M\u00fctze U, Gleich F, Bari\u0107 I, Baumgartner M, Burlina A, Chapman KA, Chien YH, Cort\u00e8s-Saladelafont E, De Laet C, Dobbelaere D, Eysken F, Gautschi M, Santer R, H\u00e4berle J, Joaqu\u00edn C, Karall D, Lindner M, Lund AM, M\u00fchlhausen C, Murphy E, Roland D, Ruiz Gomez A, Skouma A, Gr\u00fcnert SC, Wagenmakers M, Garbade SF, K\u00f6lker S, Boy N. Impact of the SARS-CoV-2 pandemic on the health of individuals with intoxication-type metabolic diseases-Data from the E-IMD consortium. J Inherit Metab Dis. 2023;46(2):220\u201331. https:\/\/doi.org\/10.1002\/jimd.12572. Epub 2022 Nov 14. PMID: 36266255; PMCID: PMC9874390.","journal-title":"J Inherit Metab Dis."},{"issue":"10","key":"2052_CR22","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3389\/fphar.2019.00918","volume":"23","author":"J Sota","year":"2019","unstructured":"Sota J, Rigante D, Ruscitti P, Insalaco A, Sfriso P, de Vita S, Cimaz R, Lopalco G, Emmi G, La Torre F, Fabiani C, Olivieri AN, Cattalini M, Cammelli D, Gallizzi R, Alessio M, Manna R, Viapiana O, Frassi M, Pardeo M, Maier A, Salvarani C, Talarico R, Mosca M, Colafrancesco S, Priori R, Maggio MC, Gaggiano C, Grosso S, De Benedetti F, Vitale A, Giacomelli R, Cantarini L. Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease. Front Pharmacol. 2019;23(10):918. https:\/\/doi.org\/10.3389\/fphar.2019.00918. PMID:31507416;PMCID:PMC6715768.","journal-title":"Front Pharmacol"},{"issue":"9","key":"2052_CR23","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3389\/fphar.2018.01526","volume":"8","author":"J Sota","year":"2019","unstructured":"Sota J, Insalaco A, Cimaz R, Alessio M, Cattalini M, Gallizzi R, Maggio MC, Lopalco G, La Torre F, Fabiani C, Pardeo M, Olivieri AN, Sfriso P, Salvarani C, Gaggiano C, Grosso S, Bracaglia C, De Benedetti F, Rigante D, Cantarini L. Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis. Front Pharmacol. 2019;8(9):1526. https:\/\/doi.org\/10.3389\/fphar.2018.01526. PMID:30670972;PMCID:PMC6331484.","journal-title":"Front Pharmacol"},{"issue":"3","key":"2052_CR24","doi-asserted-by":"publisher","first-page":"102763","DOI":"10.1016\/j.autrev.2021.102763","volume":"20","author":"G Cavalli","year":"2021","unstructured":"Cavalli G, Colafrancesco S, Emmi G, Imazio M, Lopalco G, Maggio MC, Sota J, Dinarello CA. Interleukin 1\u03b1: a comprehensive review on the role of IL-1\u03b1 in the pathogenesis and treatment of autoimmune and inflammatory diseases. Autoimmun Rev. 2021;20(3):102763. https:\/\/doi.org\/10.1016\/j.autrev.2021.102763. Epub 2021 Jan 20. PMID: 33482337.","journal-title":"Autoimmun Rev."},{"issue":"12","key":"2052_CR25","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1093\/rheumatology\/keab419","volume":"60","author":"J Sota","year":"2021","unstructured":"Sota J, Rigante D, Cimaz R, Cattalini M, Frassi M, Manna R, Sicignano LL, Verrecchia E, Aragona E, Maggio MC, Lopalco G, Emmi G, Parronchi P, Cauli A, Wiesik-Szewczyk E, Hern\u00e1ndez-Rodr\u00edguez J, Gaggiano C, Tarsia M, Mourabi M, Ragab G, Vitale A, Fabiani C, Frediani B, Lamacchia V, Renieri A, Cantarini L, Autoinflammatory Diseases Alliance (AIDA) and the Autoinflammatory Diseases Working Group of the Italian Society of Rheumatology (SIR). Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA Registry. Rheumatology (Oxford). 2021;60(12):5705\u201312. https:\/\/doi.org\/10.1093\/rheumatology\/keab419. PMID: 33961014.","journal-title":"Rheumatology (Oxford)."},{"issue":"8","key":"2052_CR26","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s10067-018-4119-x","volume":"37","author":"J Sota","year":"2018","unstructured":"Sota J, Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, Cattalini M, Manna R, Cimaz R, Priori R, Talarico R, de Marchi G, Frassi M, Gallizzi R, Soriano A, Alessio M, Cammelli D, Maggio MC, Gentileschi S, Marcolongo R, La Torre F, Fabiani C, Colafrancesco S, Ricci F, Galozzi P, Viapiana O, Verrecchia E, Pardeo M, Cerrito L, Cavallaro E, Olivieri AN, Paolazzi G, Vitiello G, Maier A, Silvestri E, Stagnaro C, Valesini G, Mosca M, de Vita S, Tincani A, Lapadula G, Frediani B, De Benedetti F, Iannone F, Punzi L, Salvarani C, Galeazzi M, Angotti R, Messina M, Tosi GM, Rigante D, Cantarini L, \u201cWorking Group\u201d of Systemic Autoinflammatory Diseases of SIR (Italian Society of Rheumatology). Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study. Clin Rheumatol. 2018;37(8):2233\u201340. https:\/\/doi.org\/10.1007\/s10067-018-4119-x. Epub 2018 May 17. PMID: 29770930.","journal-title":"Clin Rheumatol."},{"issue":"7","key":"2052_CR27","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fphar.2016.00380","volume":"24","author":"A Vitale","year":"2016","unstructured":"Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, Cattalini M, Manna R, Cimaz R, Priori R, Talarico R, Gentileschi S, de Marchi G, Frassi M, Gallizzi R, Soriano A, Alessio M, Cammelli D, Maggio MC, Marcolongo R, La Torre F, Fabiani C, Colafrancesco S, Ricci F, Galozzi P, Viapiana O, Verrecchia E, Pardeo M, Cerrito L, Cavallaro E, Olivieri AN, Paolazzi G, Vitiello G, Maier A, Silvestri E, Stagnaro C, Valesini G, Mosca M, de Vita S, Tincani A, Lapadula G, Frediani B, De Benedetti F, Iannone F, Punzi L, Salvarani C, Galeazzi M, Rigante D, Cantarini L. A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. Front Pharmacol. 2016;24(7):380. https:\/\/doi.org\/10.3389\/fphar.2016.00380. (PMID:27822185;PMCID:PMC5076463).","journal-title":"Front Pharmacol"},{"issue":"8","key":"2052_CR28","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.autrev.2018.01.024","volume":"17","author":"I Kone-Paut","year":"2018","unstructured":"Kone-Paut I, Cimaz R, Herberg J, Bates O, Carbasse A, Saulnier JP, Maggio MC, Anton J, Piram M. The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases series. Autoimmun Rev. 2018;17(8):768\u201374. https:\/\/doi.org\/10.1016\/j.autrev.2018.01.024. (Epub 2018 Jun 6 PMID: 29885546).","journal-title":"Autoimmun Rev"},{"key":"2052_CR29","doi-asserted-by":"publisher","unstructured":"Taddio A, Della Paolera S, Abbagnato L, Agrusti A, Badolato R, Biscaro F, Caorsi R, Consolaro A, Dellepiane RM, Fabi M, Floretta I, Gattorno M, Giangreco M, La Torre F, Maggio MC, Mambelli L, Mauro A, Mastrolia MV, Meneghel A, Montin D, Ricci F, Simonini G, Smarrazzo A, Sottile R, Stucchi S, Tardi M, Verdoni L, Zuccotti G, Zunica F, Ravelli A, Cattalini M; Italian Society of Pediatric Rheumatology (ReumaPed). Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children, regardless of disease severity. Rheumatology (Oxford). 2024;63(2):366\u201375. https:\/\/doi.org\/10.1093\/rheumatology\/kead381. PMID: 37647645.","DOI":"10.1093\/rheumatology\/kead381"},{"issue":"1","key":"2052_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13052-024-01658-1","volume":"50","author":"MC Maggio","year":"2024","unstructured":"Maggio MC, Lembo A, Finazzo F, Alaimo A, Benfratello GF, Corsello G. Cardiovascular involvement in children with COVID-19 temporally related multisystem inflammatory syndrome (MIS-C): can cardiac magnetic resonance arrive to the heart of the problem? Ital J Pediatr. 2024;50(1):91. https:\/\/doi.org\/10.1186\/s13052-024-01658-1. (PMID:38702753;PMCID:PMC11071142).","journal-title":"Ital J Pediatr"},{"issue":"1","key":"2052_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13075-020-02167-2","volume":"22","author":"G Giancane","year":"2020","unstructured":"Giancane G, Swart JF, Castagnola E, Groll AH, Horneff G, Huppertz HI, Lovell DJ, Wolfs T, Herlin T, Dolezalova P, Sanner H, Susic G, Sztajnbok F, Maritsi D, Constantin T, Vargova V, Sawhney S, Rygg M, Oliveira SK, Cattalini M, Bovis F, Bagnasco F, Pistorio A, Martini A, Wulffraat N, Ruperto N, Paediatric Rheumatology International Trials Organisation (PRINTO). Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee. Arthritis Res Ther. 2020;22(1):71. https:\/\/doi.org\/10.1186\/s13075-020-02167-2. PMID: 32264969; PMCID: PMC7136994.","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"2052_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13052-020-00922-4","volume":"46","author":"G Serra","year":"2020","unstructured":"Serra G, Corsello G, Antona V, D\u2019Alessandro MM, Cassata N, Cimador M, Giuffr\u00e8 M, Schierz IAM, Piro E. Autosomal recessive polycystic kidney disease: case report of a newborn with rare PKHD1 mutation, rapid renal enlargement and early fatal outcome. Ital J Pediatr. 2020;46(1):154. https:\/\/doi.org\/10.1186\/s13052-020-00922-4. (PMID:33059727;PMCID:PMC7560064).","journal-title":"Ital J Pediatr"},{"issue":"1","key":"2052_CR33","first-page":"59","volume":"64","author":"M Piccione","year":"2012","unstructured":"Piccione M, Serra G, Sanfilippo C, Andreucci E, Sani I, Corsello G. A new mutation in EDA gene in X-linked hypohidrotic ectodermal dysplasia associated with keratoconus. Minerva Pediatr. 2012;64(1):59\u201364 (PMID: 22350046).","journal-title":"Minerva Pediatr"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02052-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-02052-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02052-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T06:12:40Z","timestamp":1751350360000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-025-02052-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2052"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-02052-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3912087\/v1","asserted-by":"object"}]},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"3 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and its later amendments or comparable ethical standards. The approval by ethics committee was not applicable because the data retrospectively collected were all the items needed by the follow-up of these patients and by a good clinical practice for children with MIS-C. No experimental drugs were employed, and no blood samples, other than all required in consideration of the standards of care, were done. Written informed consent was obtained from a parent and\/or legal guardian. The parents wrote the informed consent on ethics approval and consent. The written consent is in the documents in the hospital \u201cG. Di Cristina\u201d, ARNAS Palermo, Italy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors declare no conflicts of interest. Professor Giovanni Corsello is Editor-in-Chief of Italian Journal of Pediatrics.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"202"}}